Choong Ang Vaccine Laboratory Co. Ltd (072020) - Total Assets
Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) holds total assets worth ₩125.52 Billion KRW (≈ $85.06 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Choong Ang Vaccine Laboratory Co. Ltd - Total Assets Trend (2014–2025)
This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's total assets have evolved over time, based on quarterly financial data. Also see Choong Ang Vaccine Laboratory Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Choong Ang Vaccine Laboratory Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Choong Ang Vaccine Laboratory Co. Ltd's total assets of ₩125.52 Billion consist of 42.0% current assets and 58.0% non-current assets. Review Choong Ang Vaccine Laboratory Co. Ltd (072020) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 8.5% |
| Accounts Receivable | ₩4.37 Billion | 3.6% |
| Inventory | ₩22.03 Billion | 17.9% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩1.09 Billion | 0.9% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Choong Ang Vaccine Laboratory Co. Ltd share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Choong Ang Vaccine Laboratory Co. Ltd's current assets represent 42.0% of total assets in 2025, a decrease from 44.1% in 2014.
- Cash Position: Cash and equivalents constituted 8.5% of total assets in 2025, down from 12.2% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 17.9% of total assets.
Choong Ang Vaccine Laboratory Co. Ltd Competitors by Total Assets
Key competitors of Choong Ang Vaccine Laboratory Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Choong Ang Vaccine Laboratory Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.31 | 4.22 | 3.48 |
| Quick Ratio | 2.36 | 2.62 | 2.19 |
| Cash Ratio | 0.00 | 0.00 | 0.92 |
| Working Capital | ₩42.44 Billion | ₩40.31 Billion | ₩30.50 Billion |
Choong Ang Vaccine Laboratory Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Choong Ang Vaccine Laboratory Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.79 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.4% |
| Total Assets | ₩122.82 Billion |
| Market Capitalization | $57.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Choong Ang Vaccine Laboratory Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Choong Ang Vaccine Laboratory Co. Ltd's assets decreased by 0.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)
The table below shows the annual total assets of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩122.82 Billion ≈ $83.23 Million |
-0.37% |
| 2024-12-31 | ₩123.28 Billion ≈ $83.54 Million |
+3.08% |
| 2023-12-31 | ₩119.59 Billion ≈ $81.05 Million |
+4.12% |
| 2022-12-31 | ₩114.86 Billion ≈ $77.84 Million |
+1.69% |
| 2021-12-31 | ₩112.95 Billion ≈ $76.55 Million |
+7.59% |
| 2020-12-31 | ₩104.98 Billion ≈ $71.14 Million |
+8.71% |
| 2019-12-31 | ₩96.57 Billion ≈ $65.44 Million |
-0.18% |
| 2018-12-31 | ₩96.74 Billion ≈ $65.56 Million |
+18.52% |
| 2017-12-31 | ₩81.62 Billion ≈ $55.32 Million |
+10.99% |
| 2016-12-31 | ₩73.54 Billion ≈ $49.84 Million |
+18.42% |
| 2015-12-31 | ₩62.10 Billion ≈ $42.09 Million |
+2.48% |
| 2014-12-31 | ₩60.60 Billion ≈ $41.07 Million |
-- |
About Choong Ang Vaccine Laboratory Co. Ltd
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Ko… Read more